75291-85-9 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-2-chloropyridine-3-carboxamide is utilized as a building block for the synthesis of various pharmaceutical compounds. Its unique chemical structure allows it to be a key component in the development of new drugs, contributing to the advancement of medical treatments.
Used in Agrochemical Production:
In the agrochemical industry, 5-Bromo-2-chloropyridine-3-carboxamide serves as an intermediate for the production of various agrochemicals. Its incorporation in the synthesis process aids in the creation of effective products for agricultural applications, such as pesticides and herbicides, to enhance crop protection and yield.
Used in Organic Pigment Synthesis:
5-Bromo-2-chloropyridine-3-carboxamide is also employed as an intermediate in the synthesis of organic pigments. Its chemical properties enable the production of pigments with specific characteristics, such as color intensity and stability, which are valuable in various industries, including paints, coatings, and plastics.
Check Digit Verification of cas no
The CAS Registry Mumber 75291-85-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,2,9 and 1 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 75291-85:
(7*7)+(6*5)+(5*2)+(4*9)+(3*1)+(2*8)+(1*5)=149
149 % 10 = 9
So 75291-85-9 is a valid CAS Registry Number.
75291-85-9Relevant academic research and scientific papers
COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS
-
Paragraph 1758-1760, (2021/08/06)
Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.
N-ACYLPIPERIDINE ETHER TROPOMYOSIN-RELATED KINASE INHIBITORS
-
Page/Page column 187; 188, (2015/07/07)
The present invention relates to compounds of Formula (I) described herein and their pharmaceutically acceptable salts, and their use in medicine, in particular as Trk antagonists.
MET kinase inhibitors
-
Page/Page column 40-41, (2008/06/13)
The present invention is directed to compounds having the formula I or II: including salts thereof, and methods for using them for the treatment of cancer.
